These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. NICE guidelines for use of implantable cardioverter defibrillators. Saberwal B; Ahsan S Br J Hosp Med (Lond); 2015 Jun; 76(6):316-7. PubMed ID: 26053899 [No Abstract] [Full Text] [Related]
11. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations). Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697 [TBL] [Abstract][Full Text] [Related]
12. Wilkoff BL, et al. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Europace; 2017 Apr; 19(4):580. PubMed ID: 28431075 [No Abstract] [Full Text] [Related]
13. Overcoming the defects of a virtue: dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study. Sweeney MO Circulation; 2006 Jun; 113(25):2862-4. PubMed ID: 16801472 [No Abstract] [Full Text] [Related]
14. [Efficacy and safety of implantable cardioverter defibrillator avoiding routine defibrillation threshold testing]. Liu Q; Zhou S; Qi S; Zeng G; Ma X; Huang H Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 34(11):1132-5. PubMed ID: 19952404 [TBL] [Abstract][Full Text] [Related]
15. Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE. Hernández-Madrid A; Paul T; Abrams D; Aziz PF; Blom NA; Chen J; Chessa M; Combes N; Dagres N; Diller G; Ernst S; Giamberti A; Hebe J; Janousek J; Kriebel T; Moltedo J; Moreno J; Peinado R; Pison L; Rosenthal E; Skinner JR; Zeppenfeld K; Europace; 2018 Nov; 20(11):1719-1753. PubMed ID: 29579186 [TBL] [Abstract][Full Text] [Related]